A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action
- PMID: 16460699
- DOI: 10.1016/j.biopsych.2005.11.016
A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action
Abstract
Data now exist from which an accurate definition for serotonin toxicity (ST), or serotonin syndrome, has been developed; this has also lead to precise, validated decision rules for diagnosis. The spectrum concept formulates ST as a continuum of serotonergic effects, mediated by the degree of elevation of intrasynaptic serotonin. This progresses from side effects through to toxicity; the concept emphasizes that it is a form of poisoning, not an idiosyncratic reaction. Observations of the degree of ST precipitated by overdoses of different classes of drugs can elucidate mechanisms and potency of drug actions. There is now sufficient pharmacological data on some drugs to enable a prediction of which ones will be at risk of precipitating ST, either by themselves or in combinations with other drugs. This indicates that some antidepressant drugs, presently thought to have serotonergic effects in animals, do not exhibit such effects in humans. Mirtazapine is unable to precipitate serotonin toxicity in overdose or to cause serotonin toxicity when mixed with monoamine oxidase inhibitors, and moclobemide is unable to precipitate serotonin toxicity in overdose. Tricyclic antidepressants (other than clomipramine and imipramine) do not precipitate serotonin toxicity and might not elevate serotonin or have a dual action, as has been assumed.
Similar articles
-
Serotonin syndrome: is it a reason to avoid the use of tramadol with antidepressants?J Pharm Pract. 2014 Feb;27(1):71-8. doi: 10.1177/0897190013504957. Epub 2013 Oct 23. J Pharm Pract. 2014. PMID: 24153222 Review.
-
Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.Eur J Pharmacol. 2007 Jun 22;565(1-3):105-12. doi: 10.1016/j.ejphar.2007.02.059. Epub 2007 Mar 12. Eur J Pharmacol. 2007. PMID: 17400208
-
[Serotonin syndrome--several cases of this often overlooked diagnosis].Tidsskr Nor Laegeforen. 2002 Jun 30;122(17):1660-3. Tidsskr Nor Laegeforen. 2002. PMID: 12555608 Swedish.
-
[Serotonin syndrome. Several cases of this often overlooked diagnosis].Lakartidningen. 2002 May 2;99(18):2054-5, 2058-60. Lakartidningen. 2002. PMID: 12082784 Swedish.
-
Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.Aust N Z J Psychiatry. 2007 Aug;41(8):649-55. doi: 10.1080/00048670701449237. Aust N Z J Psychiatry. 2007. PMID: 17620161 Review.
Cited by
-
Predictors of Serotonin Syndrome in Acute Poisoning with 5-Hydroxytryptamine Modulators.Toxics. 2024 Jul 30;12(8):550. doi: 10.3390/toxics12080550. Toxics. 2024. PMID: 39195652 Free PMC article.
-
Influence of aging on opioid dosing for perioperative pain management: a focus on pharmacokinetics.J Anesth Analg Crit Care. 2024 Aug 1;4(1):51. doi: 10.1186/s44158-024-00182-2. J Anesth Analg Crit Care. 2024. PMID: 39085914 Free PMC article. Review.
-
Serotonin syndrome controversies: A need for consensus.World J Crit Care Med. 2024 Jun 9;13(2):94707. doi: 10.5492/wjccm.v13.i2.94707. eCollection 2024 Jun 9. World J Crit Care Med. 2024. PMID: 38855279 Free PMC article. Review.
-
The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity.Pharmaceuticals (Basel). 2024 Apr 3;17(4):461. doi: 10.3390/ph17040461. Pharmaceuticals (Basel). 2024. PMID: 38675421 Free PMC article. Review.
-
Neutrophil-to-lymphocyte ratio as a predictive biomarker for early diagnosis of depression: A narrative review.Brain Behav Immun Health. 2024 Feb 5;36:100734. doi: 10.1016/j.bbih.2024.100734. eCollection 2024 Mar. Brain Behav Immun Health. 2024. PMID: 38362135 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical